Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

Pediatric Cancer Clinical Trial

— RFAOP  

Official title:

French African Pediatric Oncology Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03803735
• Other study ID #: GFAOP
• Status: Recruiting
• Start date: January 1, 2016
• Est. completion date: December 2030

Study information

• Verified date: March 2023
• Source: French Africa Pediatric Oncology Group
• Contact: Brenda MALLON, MSC
• Phone: + 33142115411
• Email: brenda.mallon[@]gustaveroussy.fr
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population. Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.

Description:

This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome. The register also collects information on vital status, treatment abandonment and loss to follow-up. Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 2030
• Est. primary completion date: December 2025
• Gender: All
• Age group: 1 Day to 18 Years

Eligibility

Inclusion Criteria:

1. Any child presenting at any one of the participating units for treatment

2. Any child with any type of cancer

3. Any child or adolescent less than 18 years of age.

Exclusion Criteria:

1. No cancer found

2. Age greater than 18 years -

Related Conditions & MeSH terms

• Pediatric Cancer

Locations

Country	Name	City	State
Burkina Faso	Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle	Ouagadougou
Burkina Faso	Hopital Yalgado Ouedraogo	Ouagadougou
Cameroon	Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)	Yaoundé
Congo, The Democratic Republic of the	Cliniques Universitaires de Kinshasa	Kinshasa
Congo, The Democratic Republic of the	Cliniques Universitaires de Lubumbashi (CUL)	Lubumbashi
Côte D'Ivoire	CHU de Treichville à ABIDJAN	Abidjan
France	GFAOP	Villejuif	Paris
Gabon	l'Institut de Cancérologie de Libreville	Libreville
Madagascar	HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona	Antananarivo	Ampefiloha
Mali	CHU Gabriel Touré (HGT)	Bamako
Mauritania	Centre National d'Oncologie (CNO)	Nouakchott
Niger	CNLC, Centre National de Lutte contre le Cancer	Niamey
Senegal	Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001	Dakar
Togo	CHU Sylvanus Olympio	Lomé

Sponsors (2)

Lead Sponsor	Collaborator
French Africa Pediatric Oncology Group	Gustave Roussy, Cancer Campus, Grand Paris

Countries where clinical trial is conducted

Burkina Faso,  Cameroon,  Congo, The Democratic Republic of the,  Côte D'Ivoire,  France,  Gabon,  Madagascar,  Mali,  Mauritania,  Niger,  Senegal,  Togo, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of children with a suspicion of any type of cancer in a given unit	Number of children with details of : the type of cancer; the stage of the identified cancer coming into a given unit	in any 12 month period
Primary	VITAL STATUS:	Dead or alive; The number of children living; the number of children dead	in any 12 month period
Primary	Illness status	The number of children relapsed,; The number of children whos illness has progressed.	in any 12 month period
Primary	Treatment Status	The number of children who had treatment administered,; The number of children who abandoned treatment	in any 12 month period